Therefore, SOX2 can be used as a prediction marker for successful virotherapy as the expression level of SOX2 in GSCs can predict their susceptibility to ZIKV infection and subsequent virotherapy response. This evidence concerns the gene SOX2 and Zika virus infectious disease.